Company intelligence / Profile preview

SMARTLife Biosciences

Marseille, Provence-Alpes-Côte d'Azur, Francesmartlifebiosciences.com ↗

Ownership: Private
Development stage: Commercial

Overview

SMARTLife Biosciences offers rapid, local third-generation long-read DNA/RNA sequencing and advanced bioinformatics analysis for research laboratories. Their platform enables ultra-long reads (up to 300 kb), high accuracy through multiple passes per template for error correction and consensus generation, and eco-friendly processes that avoid carcinogenic reagents. The service is designed to eliminate sample transport by operating a distributed network of labs close to clients in France.

Industry: Molecular Diagnostics

Beyond the preview

Go deeper on SMARTLife Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMARTLife Biosciences.

Explore the full profile